-
Noodles in a Haystack,investors crave for more!
$NDLS jumped from $18/plate to $36100% gains on Day 1 http://www.dailystockdeals.co/#noodles#IPO
Friday, June 28, 2013
Daily Stock Deals Daily Stock Deals @TOP10STOCKS 3m Noodles in a Haystack,investors crave for more! $NDLS jumped from $18/plate to $36100% gains on Day 1 http://www.dailystockdeals.co/ #noodles #IPO
Daily Stock Deals
Stock picks for 06/28/2013: MELA,AMSC,INVE,RENN, get fresh stock picks & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Thursday, June 27, 2013
Hot Penny Stocks picks for 06/27/2013: CERE, ANTH, LEDS, SCOG, get fresh daily stock deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Wednesday, June 26, 2013
Hot Stock Picks, Hot Penny Stocks: $DTOR $HNSN $TCPS know more about #DTOR http://www.oxbridgeresearch.com/penny-stock-alerts-hot-otc-stocks-penny-stock-blogs/524-stock-to-watch-del-toro-silver-corp-dtorob-.html … #hotstocks #pennystocks @TOP10STOCKS
Hot Stock Picks, Hot Penny Stocks: $DTOR $HNSN $TCPS know more about #DTOR http://www.oxbridgeresearch.com/penny-stock-alerts-hot-otc-stocks-penny-stock-blogs/524-stock-to-watch-del-toro-silver-corp-dtorob-.html … #hotstocks #pennystocks @TOP10STOCKS
Tuesday, June 25, 2013
Hot Stock Picks for 06/25/2013: CVM, GNVC, PPHM, ASTM, get fresh daily stock deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Sunday, June 23, 2013
Teryl Resources,TRC.V/TRYLF, Profile
Teryl Resources | TRC.V/TRYLF | Profile
Teryl
Resources Corp., - TRC.V / TRYLF – has several gold prospects near
the Kinross Fort Knox Mine in Alaska, a silver/lead/zinc prospect
adjacent to Silvercorp's mine in British Columbia, and Oil & Gas
wells in Texas.
Teryl
has a 10% net profit interest in the Stepovich claims. A 100%
interest in the Westridge property and a 50% option on the Fish Creek
property, adjacent to the Gil property. Teryl sold its 20% interest
in the Gil property in Fairbanks, Alaska, to Fairbanks Gold Mining
Corp., a wholly owned subsidiary of Kinross Gold Corp., for $15
million dollars plus a ½ of 1% royalty for the life of the mine.
Teryl
owns a 30% working interest and a 10% NPI interest in the Silverknife
property, a silver/lead/zinc prospect located in Northern B.C.
adjacent to Silvercorp's silver/lead/zinc discovery.
Teryl
also has three producing oil and gas wells in Texas, these wells are
operated by Anadarko Petroleum.
Fish
Creek property
Teryl
Resources has already started a placer and hard rock diamond drilling
program on the Fish Creek property in the Fairbanks, Alaska mining
district.
The
drilling contract requires 15 days of placer diamond drilling at a
cost of $1,500 per day, for a 12 hour day. Teryl's consulting
geologist, Paul D. Gray, P.Geo. will oversee the drilling program,
core logging , and assay protocols on behalf of the Company. The
operator of the drill will be Kenn Roberts of Texas, and Pete
Rutledge, project manager.
Kenn
Roberts, a First Nations from Yukon has multiple years of drilling
experience in remote locations and has served as mineral development
advisor to First Nations.
All
recovered gold from this program will be Teryl, Inc.'s property to
divide with its partners. Keltic Bryce owns a 50% working interest
and Teryl, Inc owns a 50% working interest in the Fish Creek
property. Linux Gold Corp. retains a 5% royalty interest in Teryl,
Inc.'s interest.
The
Fish Creek property consists of 30 claims adjacent to the Gil
property, currently owned by Kinross Gold Corporation. The Gil 20%
interest, previously owned by Teryl Resources Corp., was acquired by
Kinross for $15 million dollars.
Westridge
Property
A
geological report on the Westridge gold property has been prepared by
David Adams, B.S., M.S., CPG. Teryl has appointed Pete Rutledge,
Geologist, as an independent contractor to evaluate the Westridge
property.
The
Westridge property is located approximately 16 km north of Fairbanks,
Alaska. The property consists of 48 State of Alaska mining claims
controlled by Teryl Resources Corp.
The
claims cover approximately 1,749 acres on the north flank of the main
ridge between Pedro Creek and upper Dome Creek; both of these
drainages were significant historic placer gold producers. Access to
the property is excellent: the Elliott Highway transects the
westernmost edge of the property, and the Silver Fox Mine road
transects the southwest portion of the property.
All
claim holdings comprising the property are in good standing, and no
encumbrances to future mining activities are known or anticipated.
SILVERKNIFE
PROPERTY OWNERSHIP:
•��
Teryl Resources Corp.
owns 30% working
interest
and has a 10% Net Profit Interest
(“NPI”)
•��
Minewest Silver &
Gold owns 70% subject to
the
10% NPI held by Teryl
The
Silverknife Property
(Mineral
Claims consisting of 1,594 Acres)
A
proposed Phase I exploration program consisting of a desk study
followed by a series of on-the-ground Property boundary and drill
collar location surveys, followed by geophysics and diamond drilling
with a
recommended
budget of $358,700 is recommended for the Silverknife Property. The
exploration programs (and budgets), presented herein, are designed to
identify the accurate location of the mineral titles boundary with
respect to historic drill collars and test the Silverknife Property’s
precious and base metal mineral potential and will yield enough
information to guide Minewest and Teryl subsequent mineral
exploration programs on the Property.
This profile/research report/email letter/blog/posting in forums/social-media/t/f does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities of the Company have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclosure/Disclaimer:-
OxBridge Research publishes sponsored research reports, advertorials
and corporate profiles on its portal and several other
websites/blogs, including this website/blog, owned and operated by
OxBridge and/or its affiliates.OxBridge Research is not a Broker
Dealer or a Registered Financial Adviser in any jurisdiction,
whatsoever. All the information published on its website(s) and/or
distributed to its members via various electronic means is for
general awareness and entertainment purpose only. OxBridge urges
investors to do their own due diligence and consult with their
financial adviser prior to making any investment decision. We are
expecting a payment of up to five thousand dollars in compensation
from the company/a third party/shareholder. We receive compensation
from companies for providing various IR services, including
publication, advertisement,and social media awareness, therefore our
views/opinion are inherently biased. Please read the full
disclosure/disclaimer, if you need assistance contact
Editor@OxBridgeResearch.com
OxbridgeResearch.com,
All Rights Reserved. Trademarks/logos are of their respective owners.
It's
YOUR
money - Invest WISELY
TM
Saturday, June 22, 2013
Big Gainers, Top performers from Friday 06/21/2013
| NLST | SNTA | CYTK | IBIO | OXBT | ZGNX | STP | CSUN | IMMU | MBIS |
|---|---|---|---|---|---|---|---|---|---|
| 3.17% | 12.47% | 22.03% | 8.37% | 14.05% | 2.50% | 5.63% | 6.74% | 16.24% | 2.98% |
 |
 |
|
|
|
|
|
|
|
|
| tmxmone | tmxmone | tmxmone | tmxmone | tmxmone | tmxmone | tmxmone | tmxmone | tmxmone | tmxmone |
Friday, June 21, 2013
Stock Picks for 06/21/2013:NLST, MBIS, ZGNX, IBIO, fresh daily stock deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Thursday, June 20, 2013
Stock List for 06/20/2013: ZLCS, CLSN, OTIV, VTSS, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Wednesday, June 19, 2013
Stock Watch List, 06/19/2013: IPAS, OXBT, MSTX
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Tuesday, June 18, 2013
Stock Watch List, 06/18/2013: CYTK, EDAP, COGO,ASTI, penny stocks, LUVE, MYEC,fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Monday, June 17, 2013
Stocks Watch List, 06/17/2013: BIOL, UNIS, CHTP, PACB ,fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Friday, June 14, 2013
Stocks to Watch 06/14/2013: CDXS,ETAK,CXM,VSCI
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Thursday, June 13, 2013
Stock watch list for 06/13/2013, UNTK,OSH,CLSN,Penny Stocks, GLDN, XIDE,XUII, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Wednesday, June 12, 2013
$CERE our pick from yesterday EXPLODED! up 77% $GIMO gained 50% Fact Check baby! http://www.dailystockdeals.com/ #hotpicks #hotalerts @TOP10STOCKS
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Stock watch list, 06/12/2013, BPAX, DYSL, HEB,Penny Stocks, DOMK,XIDE,FFFC,GCEI, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Tuesday, June 11, 2013
Stock watch list, 06/11/2013, BEAT, CERE, ZOOM, penny stocks worth watching, BIZM,WPNV,JAMN,WDAS, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Monday, June 10, 2013
WoW our picks from Today skyrocketed! $RSOL up 27% $STP 15% = 42% in ONE Day! fresh picks & tweets
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Stock List for 06/10/2013, solar stocks heating up again, SCTY, STP, RSOL, HSOL, hot penny stocks, HIIT, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Friday, June 7, 2013
Stock List for 06/07/2013, MSLI,OCLR,ANAD, penny stocks to watch, GLDN, JAMN, fresh daily deals & timely tweets, sign-up/follow us
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Thursday, June 6, 2013
Anavex Life Sciences, AVXL, Profile, Summary
Anavex
Life Sciences |AVXL | Profile
Anavex
Life Sciences Corp. is a biopharmaceutical company engaged in the
discovery and development of new drugs for the treatment of
neurological diseases and cancer, utilizing its proprietary drug
discovery SIGMACEPTOR™ platform. The Anavex portfolio comprises
novel, wholly owned sigma receptor agonists and antagonists. The
company’s lead drug candidate for Alzheimer’s Disease (AD),
ANAVEX 2-73, has successfully completed a Phase 1 single ascending
dose (SAD) clinical trial. The company has also started scale-up
manufacturing for ANAVEX 1-41, its second lead compound, targeting
depression and AD. With sufficient quantities of ANAVEX 1-41 in hand,
the company will be in a position to advance the program and begin
preclinical studies on large animals in the near term.
Neurological
diseases (CNS): Anavex SIGMACEPTOR™-N program involves the
discovery and development of original drug candidates, targeting
neurological diseases such as Alzheimer’s disease, epilepsy, and
depression. The company’s lead drug candidates exhibit high
affinity and selectivity to sigma receptors and also synergistic
action with other receptors, such as Muscarinic and NMDA, with strong
evidence of anti-amnesic, neuroprotective, and anxiolytic properties.
Oncology:
Anavex SIGMACEPTOR™-C program involves the discovery and
development of original drug candidates targeting cancer. The
company’s lead drug candidates exhibit high affinity to sigma
receptors with strong evidence for selective apoptosis of cancerous
cells, without affecting healthy cells, anti-metastatic and low
toxicity properties in various types of cancer such as melanoma,
prostate and pancreas, and neuropathic pain.
In
addition, several series of sigma ligands currently at different
stages of development, target stroke, diabetes, multiple sclerosis
and Parkinson’s disease.
The
Pipe Line
Anavex’s
lead drug candidate ANAVEX 2-73 -targeting Alzheimer’s Disease- is
in Phase 1 clinical trials. The company has also initiated scale-up
manufacturing of ANAVEX 1-41 targeting a range of important CNS
disorders, including depression and Alzheimer’s Disease. Three more
of its compounds (for malignant melanoma, prostatic cancer and
epilepsy) are expected to reach final preclinical stages in the near
term.
Other
early-stage preclinical research (see diagram) involves drug
candidates that target diseases like depression, neuropathic pain and
various types of cancer.
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Hot Stocks for 06/06/2013, NLST,KUTV,FCEL popular penny stocks, AVXL,OSLH,GGCO,PGVI, fresh Daily Stock Deals
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks
Wednesday, June 5, 2013
Anavex Life Sciences, AVXL, Profile, Summary
Anavex
Life Sciences |AVXL | Profile
Anavex
Life Sciences Corp. is a biopharmaceutical company engaged in the
discovery and development of new drugs for the treatment of
neurological diseases and cancer, utilizing its proprietary drug
discovery SIGMACEPTOR™ platform. The Anavex portfolio comprises
novel, wholly owned sigma receptor agonists and antagonists. The
company’s lead drug candidate for Alzheimer’s Disease (AD),
ANAVEX 2-73, has successfully completed a Phase 1 single ascending
dose (SAD) clinical trial. The company has also started scale-up
manufacturing for ANAVEX 1-41, its second lead compound, targeting
depression and AD. With sufficient quantities of ANAVEX 1-41 in hand,
the company will be in a position to advance the program and begin
preclinical studies on large animals in the near term.
Neurological
diseases (CNS): Anavex SIGMACEPTOR™-N program involves the
discovery and development of original drug candidates, targeting
neurological diseases such as Alzheimer’s disease, epilepsy, and
depression. The company’s lead drug candidates exhibit high
affinity and selectivity to sigma receptors and also synergistic
action with other receptors, such as Muscarinic and NMDA, with strong
evidence of anti-amnesic, neuroprotective, and anxiolytic properties.
Oncology:
Anavex SIGMACEPTOR™-C program involves the discovery and
development of original drug candidates targeting cancer. The
company’s lead drug candidates exhibit high affinity to sigma
receptors with strong evidence for selective apoptosis of cancerous
cells, without affecting healthy cells, anti-metastatic and low
toxicity properties in various types of cancer such as melanoma,
prostate and pancreas, and neuropathic pain.
In
addition, several series of sigma ligands currently at different
stages of development, target stroke, diabetes, multiple sclerosis
and Parkinson’s disease.
The
Pipe Line
Anavex’s
lead drug candidate ANAVEX 2-73 -targeting Alzheimer’s Disease- is
in Phase 1 clinical trials. The company has also initiated scale-up
manufacturing of ANAVEX 1-41 targeting a range of important CNS
disorders, including depression and Alzheimer’s Disease. Three more
of its compounds (for malignant melanoma, prostatic cancer and
epilepsy) are expected to reach final preclinical stages in the near
term.
Other
early-stage preclinical research (see diagram) involves drug
candidates that target diseases like depression, neuropathic pain and
various types of cancer.
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Tags:
Alzheimer’s, Alzheimers, epilepsy, depression,
irritating bowls, sleeplessness, androgel, low T, blood pressures,
high fever, low sugar
Stocks to watch for 06/05/2013, RNN, KNDI, HNR, LPR, fresh daily stocks picks & timely tweets, Daily Stock Deals
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
Get
the Fresh, Nutrient Rich, Piping Hot Picks Everyday! Sign-up,
its FREE!
Tuesday, June 4, 2013
Stock Picks for 06/04/2013, INFI,HSOL,HEB, hot penny stocks,ASCC ,TRTC,NDEV, WPNV, fresh deals at Daily Stock Deals
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
Monday, June 3, 2013
FFFC, Fast Funds Financial, Profile,Life Collateralized Mortgage Obligagtions
FastFunds
Financial | FFFC | Profile
FastFunds
Financial Corporation is a holding company currently operates in the
financial services industry segment. The company's wholly-owned
subsidiary, NET LIFE Financial Processing, Inc., has acquired the
exclusive mortgage servicing rights for NET LIFE Financial Holdings
("NET LIFE") from the holder, a Florida Trust.
NET
LIFE is a development stage enterprise that has developed and is
offering an innovative new mortgage product that is not based on
credit history (no doc) or personal guarantees. It is only secured by
the underlying collateral and a life insurance policy on the
borrower. Therefore, all that is required to qualify for a mortgage
loan is qualifying for a life insurance policy, a down payment that
usually amounts to 10% of the purchase price and verification that
the borrower has the financial ability to pay the monthly payments.
NET LIFE believes this mortgage product will be attractive to a wide
spectrum of potential borrowers including:
first
time home buyers
- borrowers who have experienced prior financial difficulties such as foreclosures, bankruptcies, late payments or credit problems; presently employed and whose current income would qualify for a mortgage loan; but who couldn't otherwise qualify
- borrowers who may wish to bypass the traditional paperwork involved in the typical underwriting process but who would otherwise qualify.
Innovative
Mortgage Products
FastFunds
Financial combined with its partner, NET LIFE, have developed an
innovative new mortgage product that is not based on credit history
(no doc) or personal guarantees. It is only secured by the underlying
collateral and a life insurance policy on the borrower. Therefore,
all that is required to qualify for a mortgage loan is qualifying for
a life insurance policy, a down payment that usually amounts to 10%
of the purchase price and verification that the borrower has the
financial ability to pay the monthly payments. NET LIFE believes this
mortgage product will be beneficial to a wide spectrum of potential
borrowers including individuals and businesses.
NET
LIFE LCMO
The
Company believes a NET LIFE LCMO (Life Collateralized Mortgage
Obligation) could substantially improve America's banking and
mortgage crisis. A NET LIFE LCMO is a residential, business or
corporate real estate mortgage which is not based on credit history;
only on the collateral.
All
that is required for which to qualify is:
(a.)
that you are healthy
(b.)
that the property maintains and sustains its stated value
(c.)
that you have the income to pay your mortgage.
All
NET LIFE LCMO mortgages are processed, managed and serviced exactly
like a conventional mortgage without all of the red-tape
qualification. NET LIFE has only reinvented the "vehicle";
not the "wheel" it rides upon.
Don't
miss the NEXT premium Alert! Sign-up,
Get Alerts, MakeMoney!®
we
received or expecting compensation from the featured company. Our
firm, principals and staff may own/buy/sell/trade stock/securities of
this company. Always Read the full Disclosure/Disclaimer. Thanks.
$FFFC our profile company are you watching? HOT penny Stock, HOT see why http://www.dailystockdeals.com/topten/fffc-fast-funds-financial-profile … #hotpenny #hotstock #hotalerts @TOP10STOCKS
Subscribe to:
Posts (Atom)